2021
HIV prevalence among non‐injecting people who use drugs and related factors in Iran: A systematic review and meta‐analysis
Gholami J, Rostam‐Abadi Y, Rahimi Y, Fotouhi A, Amin‐Esmaeili M, Rahimi‐Movaghar A. HIV prevalence among non‐injecting people who use drugs and related factors in Iran: A systematic review and meta‐analysis. Drug And Alcohol Review 2021, 41: 666-676. PMID: 34783411, DOI: 10.1111/dar.13407.Peer-Reviewed Original ResearchConceptsHuman immunodeficiency virus prevalenceHuman immunodeficiency virusOdds of HIV infectionHIV infectionSystematic reviewPrevalence of human immunodeficiency virusPrevalence of HIV infectionReduce HIV prevalenceRandom-effects modelCitation trackingHIV prevalenceImmunodeficiency virusNo significant differenceHarm reductionPWUDGeneral populationUnpublished studiesGender subgroupsComprehensive searchNational databaseMeta-analysisSignificant differencePrevalencePreventive measuresInfection
2020
Hepatitis B virus infection among people who use drugs in Iran: a systematic review, meta-analysis, and trend analysis
Rostam-Abadi Y, Rafiemanesh H, Gholami J, Shadloo B, Amin-Esmaeili M, Rahimi-Movaghar A. Hepatitis B virus infection among people who use drugs in Iran: a systematic review, meta-analysis, and trend analysis. Harm Reduction Journal 2020, 17: 81. PMID: 33087141, PMCID: PMC7579800, DOI: 10.1186/s12954-020-00424-w.Peer-Reviewed Original ResearchMeSH KeywordsHarm ReductionHepatitis BHepatitis B virusHumansIranPrevalenceSubstance Abuse, IntravenousConceptsHepatitis B virusHepatitis B virus infectionPrevalence of HBV infectionHepatitis B virus prevalenceHBV infectionSubgroups of PWIDHepatitis B virus surface antigenB virus infectionRandom-effects model meta-analysisMeta-analysisPrevalence of HBsAgEstimation of HBsAgHigh-risk groupSystematic reviewPooled prevalence of HBsAgHarm reduction interventionsMeta-regression analysisPositive HBsAgHistory of imprisonmentHBsAg prevalenceB virusConclusionThe prevalenceReduction interventionsAt-risk populationsHBsAg